Neutralization of Human Cytomegalovirus Entry into Fibroblasts and Epithelial Cells
Human cytomegalovirus (HCMV) is a leading cause of permanent birth defects, highlighting the need to develop an HCMV vaccine candidate. However, HCMV vaccine development is complicated by the varying capacity of neutralizing antibodies (NAb) to interfere in vitro with the HCMV entry routes mediating...
Main Authors: | Felix Wussow, Flavia Chiuppesi, Heidi Contreras, Don J. Diamond |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-10-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/5/4/39 |
Similar Items
-
Comparative neutralizing potencies of antibodies suggest conservation as well as mechanistic differences in human cytomegalovirus entry into epithelial and endothelial cells
by: Ying Qi, et al.
Published: (2020-04-01) -
Role of Envelope Glycoprotein Complexes in Cell-Associated Spread of Human Cytomegalovirus
by: Nina Weiler, et al.
Published: (2021-04-01) -
Association of human cytomegalovirus (HCMV) neutralizing antibodies with antibodies to the HCMV glycoprotein complexes
by: Miho Shibamura, et al.
Published: (2020-08-01) -
Pathogen at the Gates: Human Cytomegalovirus Entry and Cell Tropism
by: Christopher C. Nguyen, et al.
Published: (2018-12-01) -
Convalescent Immunity to Guinea Pig Cytomegalovirus Induces Limited Cross Strain Protection against Re-Infection but High-Level Protection against Congenital Disease
by: K. Yeon Choi, et al.
Published: (2020-08-01)